📖+10 XP
🎧+10 XP
✅+15 XP
Level A1 – BeginnerCEFR A1
2 min
70 words
- Researchers tested a new antibody treatment in patients.
- It targets the blood cancer called multiple myeloma.
- The medicine has the name linvoseltamab.
- Doctors gave several treatment cycles to participants.
- Doctors used very sensitive bone marrow tests.
- The tests did not find cancer cells afterward.
- Some patients had low white blood cells.
- Serious immune reactions did not occur.
- Results are early but appear promising.
- The team will continue testing this treatment.
Difficult words
- antibody — A protein the immune system uses to fight germs
- multiple myeloma — A blood cancer that starts in bone marrow
- bone marrow — Soft tissue inside bones that makes blood cells
- white blood cell — A blood cell that helps fight infection and diseasewhite blood cells
- promising — Showing signs of future success or good results
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Would you try a new medicine in a medical test?
- Have you ever had a blood test?
- How do you feel if a test shows no cancer?
Related articles
1 Dec 2025
January 2025 Los Angeles wildfires and the rise in virtual health visits
A study of 3.7 million Kaiser Permanente members found that the January 2025 Los Angeles wildfires caused large increases in virtual care, especially for respiratory and cardiovascular symptoms, and raised other outpatient visits.
28 Feb 2026
18 Mar 2025
5 Dec 2024
14 Dec 2025
Targeting inflammation as a way to treat depression
A federally funded review and meta-analysis found that anti-inflammatory treatments reduced depressive symptoms and eased anhedonia in people with depression who had high inflammation. The drugs were not FDA-approved for depression and would be used off-label.